No Detail Found!

Tolerability and Efficacy of Rivaroxaban Versus Warfarin for Non Vulvular Atrial Fibrillation

Author(s)
MAHBOOB UR REHMAN Pakistan Institute of Medical Sciences Islamabad,Pakistan
ASMA RAUF Bilal Hospital Rawalpindi,Pakistan
AMJAD ALI SHAH Saidu Group of Teaching Hospitals Swat,Pakistan
ANWAR ALI Kulsum International Hospital Islamabad,Pakistan
AMJAD IBRAR Gomal Medical College Dera Ismail Khan,Pakistan
ALI RAZA Cardiac Centre Pakistan Institute of Medical Sciences Islamabad,Pakistan
Abstract
Introduction: Atrial fibrillation (AF) is the most widespread chronic heart arrhythmia, affecting 1-2 % of the general population. Objectives: Patients with non-valvular atrioventricular fibrillation are the major focus of this research. Rivaroxaban is compared against warfarin in terms of tolerability and efficacy. Material and methods: This cross sectional comparative study was conducted in Pakistan Institute of Medical Sciences Islamabad during January 2020 till December 2020. A total of 120 OPD patients who satisfied the study's inclusion and exclusion criteria were included in the research after it was given the green light by the hospital's ethics committee. A complete medical history and physical examination were required to ensure that all participants met the criteria for inclusion. It was determined that obtaining express written consent was essential. Results: As indicated above, 15 individuals were removed from the study; six patients in the NOAC group refused to participate and departed the study; while four patients were lost to follow-up. In this study, rivaroxaban was administered to twenty-one participants, whereas warfarin was administered to the remaining twenty-four. Conclusion: Oral anticoagulants for stroke prevention in non-valvular AF have advanced in development, benefiting patients and clinicians alike with fewer medication and food interactions, no monitoring need, and a wider therapeutic index.
Publication Details
Page(s) 925-927
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 03, Year: 2022

Request the full text from PASTIC

Keywords
Efficacy of Rivaroxaban Versus Warfarin for Non Vulvular
0

Citations

0

Downloads

51

Views